Recently, there have been important advances in the understanding of the pathophysiologic
features, assessment, and management of patients with a newly diagnosed idiopathic …

Background An association between dermatomyositis (DM) and cancer has been reported
since 1916; however, estimates of the associated risk vary widely. For cost-effectiveness …

Objective Understanding of the personal risks for rheumatoid arthritis (RA) and other rheumatic
diseases remains poor, despite advances in knowledge with regard to their pathogenesis…

Objective To characterize the epidemiology of mixed connective tissue disease (MCTD) from
1983 to 2014. Methods An inception cohort of patients with incident MCTD in 1985–2014 in …

There has been significant progress in understanding the clinical characteristics, diagnostic
workup, treatment, disease assessment, and prognosis of JIIM patients, but more …

Objective To determine the incidence of psoriatic arthritis (PsA) in a US population and
describe trends in incidence and mortality over 5 decades. Methods The previously identified …

Objective To evaluate survival and associated comorbidities in inclusion body myositis (IBM)
in a population-based, case-control study. Methods We utilized the expanded Rochester …

Objective To examine demographic and clinical characteristics associated with diagnostic
delay in psoriatic arthritis (PsA). Methods We characterized a retrospective, population-based …

Objective We aimed to determine the population‐based incidence, prevalence, and mortality
of dermatomyositis (DM) using European Alliance of Associations for Rheumatology (…

In 2012, the Systemic Lupus International Collaborating Clinics (SLICC) group published a
new set of classification criteria for systemic lupus erythematosus (SLE). Studies applying …